In Scientific Publishing, Sharing Is Caring
The Saga for Open-Access Research Continues
Cell-Free DNA Drives Liquid Biopsy Testing
Researchers Are Diligently Finding Ways to Use Scraps of cfDNA in Clinically Relevant Ways
Raising the Bar of Cell Line Authentication
Researchers May Be Slow to Implement Protocols Unless They Are Pressured
Optical DNA Mapping Identifies Disease-Causing Mutations
Bionano Saphyr Spots Inversions and Large Deletions in Genomes
For full access to this article login to GEN Select now.
Exceptional Responders: The “N of 1” Paradigm
Hope for Better Cancer Treatments May Lie in Those Patients Who Respond Exceptionally Well
- We have all heard stories about the single patient who survives a deadly cancer in response to a particular drug, in contrast to other patients receiving the same drug who succumb to the disease. These patients may include heavily pretreated cancer patients for whom other drugs have failed, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.